Continuous intravenous infusion of enoxaparin controls thrombin formation more than standard subcutaneous administration in critically ill patients. A sub-study of the ENOKSI thromboprophylaxis RCT.
Annukka VahteraTimea SzantoRiitta LassilaMiia ValkonenMirka SivulaHeini HuhtalaVille PettiläAnne KuitunenPublished in: Acta anaesthesiologica Scandinavica (2020)
Enoxaparin thromboprophylaxis administered by CII inhibited more prominently FXa and preserved better the AT level, compared with standard subcutaneous care.